Puration Inc Sets Sights On 2018 Revenue Benchmark To Carve Out Leadership Stake In $1 Billion Cannabis Beverage Market Segment
October 09 2018 - 9:38AM
InvestorsHub NewsWire
Dallas, TX -- October 9, 2018 -- Investorshub
NewsWire -- Puration, Inc. (USOTC:
PURA) (“PURA”) today announced setting its sights on breaking
through the $1 million revenue benchmark in 2018. PURA is a
rapidly growing cannabis beverage producer and management believes
sales could exceed $1 million this year, 2018. The company
introduced EVERx CBD Sports Water last year which has become the
leading cannabis beverage brand name in the sports nutrition market
place. Distribution is growing rapidly. The company has
just launched its first production run with its new labels to fill
outstanding orders within new regions in the United States (U.S.
and internationally. The company’s first THC infused
beverage, THCSavor, is in the works and is expected to launch
soon. The company also recently announced a pending
acquisition to add yet a third cannabis beverage. According to
a report by Brightfield Group, the hemp and CBD category alone
is expected to be a $1billion market by 2020 in the
U.S..
PURA announced last week the spinoff of its cannabis
cultivation business. The spinoff is part of the overall
strategy for Puration to concentrate ongoing business development
efforts on the company’s flourishing cannabis infused beverage
business. The spinoff announced last week has been effected
through the execution of a securities exchange agreement with
Nouveau Life Pharmaceuticals, Inc., (USOTC:
NOUV) (“NOUV”). PURA has sold its cannabis
cultivation business in exchange for a convertible purchase note
issued by NOUV. All of the NOUV common shares issued in
conversion of the purchase note are slated for distribution to PURA
shareholders in a dividend distribution following a
recapitalization of NOUV.
More details on the
company’s rapidly expanding cannabis beverage business to include
further details on the spinoff transaction will be included in an
online presentation this Thursday, October 11th,
2018.
Learn more about Puration at www.purationinc.com
Disclaimer/Safe
Harbor:
This news release
contains forward-looking statements within the meaning of the
Securities Litigation Reform Act. The statements reflect the
Company's current views with respect to future events that involve
risks and uncertainties. Among others, these risks include the
expectation that any of the companies mentioned herein will achieve
significant sales, the failure to meet schedule or performance
requirements of the companies' contracts, the companies' liquidity
position, the companies' ability to obtain new contracts, the
emergence of competitors with greater financial resources and the
impact of competitive pricing. In the light of these uncertainties,
the forward-looking events referred to in this release might not
occur. These statements have not been evaluated by the Food and
Drug Administration. These products are not intended to diagnose,
treat, cure, or prevent any disease.
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350
Nouveau Life Pharmaceuti... (PK) (USOTC:NOUV)
Historical Stock Chart
From Aug 2024 to Sep 2024
Nouveau Life Pharmaceuti... (PK) (USOTC:NOUV)
Historical Stock Chart
From Sep 2023 to Sep 2024